2018 Health for Humanity Report Progress in Citizenship & Sustainability 2018 Health for Humanity Report 2 Overview Our Approach Better Health for All Our People Responsible Business Practices Environmental Health Appendix References Contents Overview 3 Our People 62 Environmental Health 116 Johnson & Johnson At-A-Glance 3 Attracting the Most Talented People 64 EHS&S Management 118 Our Credo 5 Creating Unique Career Opportunities 68 Climate & Energy 119 Message from Our Leaders 6 Engaging, Empowering and Inspiring 71 Waste & Water Management 126 2018 Year in Brief 10 Advancing Diversity & Inclusion 75 Product Sustainability 129 Providing Safe Workplaces 78 Our Approach 12 Championing Health & Wellness 81 Appendix 135 Health for Humanity Strategy & Progress 13 GRI Index 136 Sustainability Governance 21 Responsible Business Practices 83 UNGC Index 136 Setting Priorities 22 Product Quality, Safety & Reliability 84 Data Summary 136 Engaging with Our Stakeholders 23 Ethics & Transparency 94 About This Report 137 Respect for Human Rights 101 Independent Assurance Statements 138 Better Health for All 26 Information Security & Privacy 103 World Without Disease 27 Strong Corporate Governance 105 References 144 Enhancing Access to Healthcare 40 Responsible Supply Base 107 Innovating for Better Health 44 Strengthening Health Systems 51 Contributing to Community Health 56 2018 Health for Humanity Report 3 Overview Our Approach Better Health for All Our People Responsible Business Practices Environmental Health Appendix References Overview The Johnson & Johnson The Johnson & Johnson ~260 Medical Devices Family of Consumer operating companies Companies Companies Johnson & Johnson Comprised of surgical, Offers the world’s largest range of 140,861 employees At-A-Glance orthopaedic, eye health, medical consumer health products. From GRI 102-1, 102-2, 102-3, 102-4, 102-5, 102-6, 102-7 specialty businesses as well baby care and oral care to beauty, as interventional solutions for health and healing, we anticipate cardiovascular and neurovascular needs and create solutions and Our Purpose disease. Representing the most experiences to help people live ~60 comprehensive surgical technology healthy, vibrant lives. countries of operation Johnson & Johnson is the largest and most and specialty solutions business diversified healthcare company in the world. We in the world, the group offers an 2018 Sales: $13,853 million have been caring for people since 1886. unparalleled breadth of products, services, programs and R&D $10,775M Our Values capabilities directed at advancing R&D investment patient care while delivering clinical We are driven by Our Credo, a set of values and and economic value to healthcare principles that challenges and inspires us to put the The Janssen systems worldwide. needs and wellbeing of the people we serve first. Pharmaceutical Companies of Johnson & Johnson $81,581M 2018 Sales: $26,994 million total sales Our Business Our global headquarters are in New Brunswick, New Jersey, USA. Johnson & Johnson has been Address some of the most listed on the New York Stock Exchange since 1944 devastating and complex diseases $15,297M under the symbol JNJ. For changes in our business of our time, focusing on six net earnings during the reporting period, please visit page 71 of therapeutic areas: immunology, infectious diseases and vaccines, our 2018 Annual Report. neuroscience, oncology, cardiovascular and metabolism, $127.27 and pulmonary hypertension. By market price per share, investing in a transformative future, year-end close we are changing the way diseases are prevented, intercepted, treated and cured. 2018 Sales: $40,734 million 2018 Health for Humanity Report 4 Overview Our Approach Better Health for All Our People Responsible Business Practices Environmental Health Appendix References Our Brands Every day, we touch millions of lives with our products. Following are select brands that represent the diversity of the Johnson & Johnson product portfolio in our three business segments, spanning the continuum of healthcare. Consumer Medical Devices Pharmaceutical 2018 Health for Humanity Report 5 Overview Our Approach Better Health for All Our People Responsible Business Practices Environmental Health Appendix References Our Credo GRI 102-16 come. These conversations were then replicated by teams across the Enterprise to inspire individual accountability and commitment. At the core, these changes reflect Johnson & Johnson's More commitment to all of humanity, and push thinking beyond the traditional definition of health to provide people with solutions and Resources experiences that improve their whole life. We brought patients to the front of the list of stakeholders in the first paragraph of 133 Years of Innovative Credo-Driven Our Credo as we know they are waiting for our life-saving and Decisions That Have Made life-enhancing products and solutions. We added inclusion, Johnson & Johnson the Healthcare fulfillment and purpose to the second paragraph of Our Credo as Leader It Is Today not only are diversity and inclusion the way we've done business for more than 130 years, but we know that it's not enough to have a diverse workforce in order to be successful. We need to create Johnson & Johnson employees in Asia-Pacific region an environment where people are supported and empowered The Power of Our Credo: celebrating the global Credo Day. to bring forward their unique backgrounds, driving innovation in Johnson & Johnson Chairman and service of our shared purpose to change the trajectory of health for CEO Alex Gorsky Reflects on the humanity. These and other enhancements reflect the Company's Legacy of the Company's Historic responsibility to ensure it remains just as forward-thinking as the In 2018, Johnson & Johnson marked the 75th anniversary of Mission Statement day it was introduced. Our Credo, the set of values that ground and guide the decision making of our employees around the world. In addition to On December 13, 2018, the Company held its first annual Credo celebrating the enduring power of this document, for the first time Day celebration, commemorating 75 years from the date that in more than three decades, we updated Our Credo to ensure it General Johnson first presented Our Credo to the Board of remains both timeless and timely. Directors in 1943. More than 30,000 employees in locations around the world participated in a Global Town Hall, attended unique These enhancements were informed and shaped by the feedback celebrations, and joined outreach efforts to bring the spirit of the of our employees around the world. Employees were challenged Credo to their local communities. to expand their understanding of our commitments, reflect and have open conversations about opportunities to better live Our Our Credo is more than words—it is a set of promises to Credo, and take ownership of each responsibility through daily which every individual, team and company across our business actions. The Executive Committee led in-depth conversations on are actively dedicated everyday. Most importantly, these each paragraph, discussing with employees how we are living our enhancements ensure Our Credo positions us to continue to place values, where we can show up stronger for those we serve, and the needs of those we serve at the forefront of everything we do. how we can continue to improve human health for generations to 2018 Health for Humanity Report 6 Overview Our Approach Better Health for All Our People Responsible Business Practices Environmental Health Appendix References Message from Our Leaders GRI 102-14 Statement from Chairman & CEO At Johnson & Johnson, we know that meeting those challenges head on means addressing disease along the Dear Johnson & Johnson Stakeholders, entire continuum of health: from prevention to interception to 2018 marked a meaningful anniversary for our Company. cure. We’re making great progress on our preventive HIV and Ebola vaccines. As a committed partner in the global fight Seventy-five years ago, we enshrined one of our most against tuberculosis (TB), we’re delivering on our Health for enduring values into Our Credo: to put the needs and Humanity 2020 Goal to treat the disease by increasing access wellbeing of those we serve first. By always prioritizing those to our multidrug-resistant TB therapy, bedaquiline. we serve—something we’ve done since our founding—we’ve grown from a purveyor of surgical dressings to the largest You can also see our commitment to expanding access in our broadly based healthcare company in the world. second annual Janssen U.S. Transparency Report. It details all the ways we’re working to secure and expand patient access At Johnson & Johnson, we believe we’re uniquely positioned while leading in our commitment to visible, accountable Alex Gorsky meeting with employees on his visit and responsible drug pricing practices in the United States. to bring together science, people, technology and the ideas to Australia. needed to profoundly change the trajectory of health for Globally, we make the same commitment to expand access humanity. That scale and reach come with a huge sense of and it helped land us a #3 position on the Access to Medicine responsibility—every decision we make can have an enduring Index. supporting our employees with everything from best-in- impact across the globe. class health programs to investing in their personal and We recognize that we cannot solve all the pressing professional growth. Our 2018 Health for Humanity Report is an invitation for you healthcare challenges alone and are proud to work in close to experience the work we do. You’ll see how our ethos of partnership with healthcare organizations around the world. Putting the needs of those we serve first also means results, transparency and accountability runs through our key In sub-Saharan Africa, for example, we’re piloting a series protecting our shared environment and natural resources. focus areas: better health for the whole world, investing in of collaborations to create an affordable, scalable quality Our Consumer business segment joined 240 other our people, responsible business practices and safeguarding care model for the treatment of severe mental illness.